# BioXcel Therapeutics, Inc. (BTAI) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$50M |
| 2024 | -$67M |
| 2023 | -$172M |
| 2022 | -$160M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$10M |
| 2025-09-30 | -$14M |
| 2025-06-30 | -$16M |
| 2025-03-31 | -$10M |
| 2024-09-30 | -$15M |
| 2024-06-30 | -$17M |
| 2024-03-31 | -$24M |
| 2023-09-30 | -$48M |
| 2023-06-30 | -$52M |
| 2023-03-31 | -$51M |
| 2022-09-30 | -$39M |
| 2018-09-30 | -$5M |
| 2018-06-30 | -$3M |
| 2018-03-31 | -$4M |
| 2017-09-30 | -$917,000 |
| 2017-06-30 | -$565,000 |
| 2017-03-31 | -$529,000 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/BTAI/operating-income)